COVID-19 Research Perspective Volume 12, Issue 8 pp 6492—6510

Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections

Figure 1. COVID-19 as a gerophilic and gerolavic infection. (A) Distribution of patients diagnosed in the city of Wuhan only through February 11, 2020. (B) Age distribution of the infected and diseased patients in Mainland China through February 11, 2020. The figures are adopted and generated from [12] (http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51).